0001209191-23-060007.txt : 20231229
0001209191-23-060007.hdr.sgml : 20231229
20231229163348
ACCESSION NUMBER: 0001209191-23-060007
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231228
FILED AS OF DATE: 20231229
DATE AS OF CHANGE: 20231229
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Elam Nevan C
CENTRAL INDEX KEY: 0001314773
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32157
FILM NUMBER: 231528140
MAIL ADDRESS:
STREET 1: C/O NEKTAR THERAPEUTICS
STREET 2: 150 INDUSTRIAL ROAD
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Savara Inc
CENTRAL INDEX KEY: 0001160308
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 841318182
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6836 BEE CAVE ROAD
STREET 2: BUILDING 3, SUITE 201
CITY: AUSTIN
STATE: TX
ZIP: 78746
BUSINESS PHONE: 51285113796
MAIL ADDRESS:
STREET 1: 6836 BEE CAVE ROAD
STREET 2: BUILDING 3, SUITE 201
CITY: AUSTIN
STATE: TX
ZIP: 78746
FORMER COMPANY:
FORMER CONFORMED NAME: Mast Therapeutics, Inc.
DATE OF NAME CHANGE: 20130312
FORMER COMPANY:
FORMER CONFORMED NAME: ADVENTRX PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20030613
FORMER COMPANY:
FORMER CONFORMED NAME: BIOKEYS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20010928
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-12-28
0
0001160308
Savara Inc
SVRA
0001314773
Elam Nevan C
ONE SUMMIT SQUARE,
1717 LANGHORNE NEWTOWN ROAD, SUITE 300
LANGHORNE
PA
19047
1
0
0
0
0
Common Stock
2023-12-28
4
M
0
1758
0.82
A
64343
D
Common Stock
2023-12-28
4
M
0
12000
1.59
A
76343
D
Common Stock
2023-12-28
4
M
0
40000
1.23
A
116343
D
Common Stock
2023-12-28
4
S
0
93843
4.7131
D
22500
D
Stock Option (Right to Buy)
0.82
2023-12-28
4
M
0
1758
0.00
D
2024-07-24
Common Stock
1758
0
D
Stock Option (Right to Buy)
1.59
2023-12-28
4
M
0
12000
0.00
D
2029-12-20
Common Stock
12000
0
D
Stock Option (Right to Buy)
1.23
2023-12-28
4
M
0
40000
0.00
D
2030-12-16
Common Stock
40000
0
D
The price is a weighted average sales price. The sale prices ranged from $4.70 to $4.795. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on October 24, 2014.
The shares subject to the option vested and became exercisable in twelve equal installments on each quarterly anniversary of December 20, 2019.
The shares subject to the option vested and became exercisable on December 16, 2021.
/s/ David Lowrance, as attorney-in-fact for Nevan Elam
2023-12-29